Three Demand Curves for Molybdenum in New Energy: Solar, Hydrogen and Nuclear

When it comes to molybdenum demand, steel accounts for the bulk, but the growth story is now unfolding in new energy. On the three technology routes of photovoltaics, hydrogen and nuclear power, molybdenum plays a different role and the certainty of demand differs as well. This article takes them one by one and sets out what to watch when judging the trend.

Curve One: Photovoltaics, from Hot Zones to Thin Films

Photovoltaic demand for molybdenum has two layers. At the equipment layer, hot zones in crystal pullers and casting furnaces for crystal and ingot growth use large quantities of molybdenum components: crucible supports, heat shields and electrodes work in a long-term high-temperature vacuum environment, and the trend toward larger crystals is driving upgrades in component size. At the material layer, copper indium gallium selenide (CIGS) thin-film cells use a molybdenum layer as the back contact, a standard feature of the thin-film route. Both layers track installation volumes and capacity build-out cycles, and peaks in equipment investment are typically peaks in orders for molybdenum components.

Curve Two: Hydrogen, the Frontier of Materials Research

Electrode materials for water electrolysis are currently dominated by nickel-based and precious-metal systems. Molybdenum compounds such as molybdenum carbide and molybdenum disulfide, with their precious-metal-like catalytic behavior, are an active direction of research in electrolysis and hydrogen evolution catalysis: laboratory results are plentiful, but industrialization will take time. For the molybdenum industry, hydrogen is at present more of a long-dated option: demand elasticity is high, while the path and timeline to commercialization remain unclear. Tracking the scale of demonstration projects is more practical than chasing the concept.

Curve Three: Nuclear Power and Medical Isotopes

The established application of molybdenum in nuclear energy is on the medical side: technetium-99m, the decay product of molybdenum-99, is the most widely used radioisotope in nuclear medical imaging, and medical supply systems worldwide have long depended on steady production of molybdenum-99, with the associated targets and separation facilities generating continuous material demand. In nuclear structural materials, molybdenum-bearing stainless steels and alloys are standard; molybdenum alloys also have a place in research on new structural materials for fast reactors and small modular reactors, though this is a long-cycle variable.

How to Judge the Substance Behind These Trends

The certainty of demand across the three curves ranks as follows: photovoltaics, already realized and tracking installation and capacity expansion cycles, then nuclear and medical, with a stable base volume and incremental demand from new reactors and isotope capacity, then hydrogen, hot in research and distant in deployment. Tracking should focus on three signals: the scale of equipment tenders, announcements of thin-film cell capacity construction, and progress of medical isotope capacity projects. For material suppliers, preparing early for specification upgrades and delivery capability in hot-zone components is more prudent than betting on a single emerging concept. Capabilities for high-temperature components are described in our company profile and in the technology and processes section.